Glioblastoma multiforme - Treating a deadly tumor with both strands of RNA

PLoS Medicine

Volumn 3, Issue 1, 2006, Pages 21-23

  Weil, Robert J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR; RNA; EPIDERMAL GROWTH FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID;

ASTROCYTOMA; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; GENE OVEREXPRESSION; GLIOBLASTOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; MUTATION; OLIGODENDROGLIOMA; ONCOGENE; PROGNOSIS; SHORT SURVEY; TUMOR CELL; ANIMAL; APOPTOSIS; METABOLISM; MOUSE; NOTE; PATHOLOGY;

ANIMALS; APOPTOSIS; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; MICE; POLY I-C; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, DOUBLE-STRANDED;

EID: 32044455134     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030031     Document Type: Short Survey

References (12)

1. Berger MS, Wilson CB, editors (1999) The gliomas. 1st edition. Philadelphia: WB Saunders. 796 p.
2. Kleihues P, Cavenee W (2000) Pathology and genetics of tumors of the nervous system. Lyon: IARC Press. 314 p.
3. Holland EC (2001) Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet 2: 120-129.
4. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, et al. (2001) Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
5. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, et al. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95: 190-198.
6. Shir A, Ogris M, Wagner E, Levitzki A (2006) EGF receptor targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice. PLoS Med 2: e6. DOI: 10.1371/journal.pmed.0030006
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
8. Kapoor GS, O'Rourke DM (2003) Receptor tyrosine kinase signaling in gliomagenesis: Pathobiology and therapeutic approaches. Cancer Biol Ther 2: 330-342.
9. von Herrath MG, Bot A (2003) Immune reponsiveness, tolerance and dsRNA: Implications for traditional paradigms. Trends Immunol 24: 289-292.
10. Fire A (1999) RNA-triggered gene silencing. Trends Genet 15: 358-363.
11. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, et al. (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91: 2076-2080.
12. Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3: 1362-1368.